Halda Therapeutics
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic
1
Funding Rounds
$126.0m
Money raised
Overview
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic
| Name | Phone | Social networks | |
|---|---|---|---|
| Cr*** Cr*** |
|
- |
Funding series
Funding Series Analysis
The company Halda Therapeutics has raised a total of $126m in funding over 1 rounds.
Key Insights:
- Halda Therapeutics August 2024 Series B Funding Round: $126m
Halda Therapeutics August 2024 Series B Funding Round
$126m
Industries
Halda Therapeutics is active in the following industries: